Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Molecular Pharmacology|May 7, 2011
Dry age-related macular degeneration: recent progress of therapeutic approachesNoriyuki Kuno, Shinobu Fujii
Drugs & Aging|January 29, 2010
Biodegradable intraocular therapies for retinal disorders: progress to dateNoriyuki Kuno, Shinobu Fujii
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2015
Functional Characterization of Carrier-Mediated Transport of Pravastatin across the Blood-Retinal Barrier in RatsShinobu Fujii, Chikako Setoguchi, Kouichi Kawazu, et al.
Investigative Ophthalmology & Visual Science|July 3, 2014
Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout ratsShinobu Fujii, Chikako Setoguchi, Kouichi Kawazu, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinaseToshikazu Hakogi, Shinobu Fujii, Michio Morita, et al.
The Journal of Pharmacy and Pharmacology|January 3, 2013
Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cellsShinobu Fujii, Hideki Hayashi, Kunihiko Itoh, et al.
Biological & Pharmaceutical Bulletin|July 5, 2003
His151 and His296 are the acid-base catalytic residues of Bacillus cereus sphingomyelinase in sphingomyelin hydrolysisTakashi Obama, Shinobu Fujii, Hiroh Ikezawa, et al.
Archives of Biochemistry and Biophysics|March 31, 2005
Activation of sphingomyelinase from Bacillus cereus by Zn2+ hitherto accepted as a strong inhibitorShinobu Fujii, Hiromi Itoh, Ayumi Yoshida, et al.
Pageof 3